UNSPSC 51473013: Oxyquinoline

This classification denotes a topical anti-infective agent with the molecular formula C9H7NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5UTX5635HP, chemically known as 8-quinolinol (7ci,8ci,9ci) but generally known as 8-hydroxyquinoline, which bears US NIH Compound Identifier 1923. European Medicines Agency schedules Oxyquinoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25866.

World Health Organization schedules 8-hydroxyquinoline in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, OXYQUINOLINE remains the US FDA Preferred Term for this commodity. Oxyquinoline bears US NLM identifiers UMLS ID C0000665 and NCI Concept Code C80862. SMILES: C1=CC2=C(C(=C1)O)N=CC=C2.

UNSPSC 51473013 Oxyquinoline, a Commodity code, covers chemical compounds and active pharmaceutical ingredients used in janitorial supplies, over-the-counter medications, and institutional consumables procured by state and local government agencies. State and local buyers under this code include county governments, state purchasing alliances, and institutional facilities operated by public agencies; the recent opportunities show solicitation activity from Hillsborough County Board of County Commissioners (Florida) and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, which coordinates procurement across participating state and local government entities in multiple states including Oregon.

Geographic activity appears concentrated in Florida and Minnesota with broader reach through cooperative purchasing vehicles. Hillsborough County Board of County Commissioners issued ITB 26-00319 on July 7, 2026, seeking janitorial and operational supplies for the Hillsborough County Fire Rescue Department across 47 fire stations, with bids due July 24, 2026 and an estimated contract value of $765,679.84 for one year; products must be new, unused, and in original packaging with delivery within ten days of purchase order receipt to Tampa, Florida. MMCAP issued an RFP (S1070000015802) on January 20, 2026, for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 response deadline and July 1, 2026 contract effective date; vendors must supply through three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co.), maintain cGMP and Drug Supply Chain Security Act compliance, and carry commercial general liability insurance of $5,000,000 per occurrence, with awards effective through June 30, 2028 for incumbent responders.